首页> 美国卫生研究院文献>Clinical Medicine Insights. Oncology >Antitumor Efficacy of Intravesical BCG Gemcitabine Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model

【2h】

Antitumor Efficacy of Intravesical BCG Gemcitabine Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model

机译：原位肿瘤模型膀胱内BCG吉西他滨干扰素-α和白介素-2作为膀胱癌单药或联合疗法的抗肿瘤功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective:To reduce adverse effects and improve efficacy of intravesical BCG for bladder cancer, alternative treatment options were investigated in an orthotopic rat tumor model.

机译：目的：为减少膀胱癌中膀胱卡介苗的不良反应并提高其疗效，在原位大鼠肿瘤模型中研究了替代治疗方案。

著录项

期刊名称 Clinical Medicine Insights. Oncology
作者
Zhengwen Xiao; Erich Hanel; Allan Mak; Ronald B. Moore;
展开▼
作者单位

展开▼
年(卷),期 2011(5),-1
年度 2011
页码 315–323
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
BCG bladder cancer gemcitabine interferon-α intravesical therapy;

机译：卡介苗;膀胱癌;吉西他滨;干扰素-α;膀胱内治疗;

相似文献

外文文献
中文文献
专利

1. Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model [J] . Zhengwen Xiao, Erich Hanel, Allan Mak, Clinical Medicine Insights: Oncology . 2011,第5期

机译：卡介苗卡介苗，吉西他滨，干扰素-α和白介素-2作为原发性肿瘤模型膀胱癌的单药或联合疗法的抗肿瘤功效
2. Enhanced antitumor effect of coincident intravesical gemcitabine plus BCG therapy in an orthotopic bladder cancer model. [J] . Horinaga M, Fukuyama R, Iida M, Urology . 2010,第5期

机译：同时膀胱内吉西他滨联合卡介苗治疗在原位膀胱癌模型中的增强抗肿瘤作用。
3. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers (Retration of vol 79, pg 218, 2010) [J] . Tharakan Sheeja T., Inamoto Teruo, Sung Bokyung, Biochemical Pharmacology . 2016,第Null期

机译：姜黄素通过抑制增殖和血管生成生物标志物来增强吉西他滨在人膀胱癌原位模型中的抗肿瘤作用（Retration of vol 79，pg 218，2010）
4. In vivo fluorescence imaging of an orthotopic rat bladder tumor model indicates differential uptake of intravesically instilled near-infrared labeled 2-deoxyglucose analog by neoplastic urinary bladder tissues [C] . Daqing Piao, Carole A. Davis, Robert E. Hurst, Therapeutics and Diagnostics in Urology: Lasers, Robotics, Minimally Invasive, and Advanced Biomedical Devices . 2017

机译：原位大鼠膀胱肿瘤模型的体内荧光成像显示肿瘤性膀胱组织对膀胱内滴注的近红外标记的2-脱氧葡萄糖类似物的摄取差异
5. Targeting the ERβ/HER Oncogenic Network in Lung Cancer: Synergistic Antitumor Interaction and Potentiation of Anti-PD1 Efficacy [D] . Almotlak, Abdulaziz A. 2020

机译：靶向肺癌中的ERβ/致癌网络：协同抗肿瘤相互作用和抗PD1功效的增强性
6. Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model [O] . MASASHI MATSUSHIMA, MINORU HORINAGA, RYUICHI FUKUYAMA, -1

机译：膀胱丝裂霉素C和卡介苗芽孢杆菌联合疗法在原位膀胱癌模型中的抗肿瘤作用增强
7. Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model [O] . Xiao, Zhengwen, Hanel, Erich, Mak, Allan, 2011

机译：膀胱癌中膀胱BCG，吉西他滨，干扰素-α和白介素-2作为单药或联合疗法在原位肿瘤模型中的抗肿瘤功效

Antitumor Efficacy of Intravesical BCG Gemcitabine Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model

摘要

著录项

相似文献

相关主题

期刊订阅